Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Stereotaxis, Inc. (STXS)

NYSE American - NYSE American Delayed Price. Currency in USD
2.0200-0.1000 (-4.72%)
At close: 04:00PM EST
Advertisement

Stereotaxis, Inc.

710 North Tucker Boulevard
Suite 110
Saint Louis, MO 63101
United States
314 678 6100
https://www.stereotaxis.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees130

Key Executives

NameTitlePayExercisedYear Born
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A., CFA, CPACEO & Chairman62.2kN/A1987
Ms. Kimberly R. PeeryCFO & Sec.269.82kN/AN/A
Mr. Keith GallowayVP of OperationsN/AN/AN/A
Ms. Laura Spencer GarthGen. CounselN/AN/AN/A
John PlattSr. Director of Project Management & Systems SoftwareN/AN/AN/A
Nathan KasteleinR&D Leader and Sr. Director of R&D and Advanced ConceptsN/AN/AN/A
Brian KiddR&D Leader and Sr. Director of Product Devel.N/AN/AN/A
Mr. Guy JudkowskiEquity Portfolio Mang.N/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.

Corporate Governance

Stereotaxis, Inc.’s ISS Governance QualityScore as of December 1, 2022 is 8. The pillar scores are Audit: 7; Board: 8; Shareholder Rights: 10; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement